chr16-28905724-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_024816.3(RABEP2):c.1471G>T(p.Val491Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000261 in 1,614,030 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024816.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RABEP2 | NM_024816.3 | c.1471G>T | p.Val491Leu | missense_variant | 11/13 | ENST00000358201.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RABEP2 | ENST00000358201.9 | c.1471G>T | p.Val491Leu | missense_variant | 11/13 | 1 | NM_024816.3 | P1 | |
RABEP2 | ENST00000357573.10 | c.1363G>T | p.Val455Leu | missense_variant | 9/11 | 1 | |||
RABEP2 | ENST00000544477.5 | c.1258G>T | p.Val420Leu | missense_variant | 10/12 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000342 AC: 52AN: 152222Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000298 AC: 74AN: 248722Hom.: 0 AF XY: 0.000274 AC XY: 37AN XY: 135066
GnomAD4 exome AF: 0.000252 AC: 369AN: 1461690Hom.: 0 Cov.: 34 AF XY: 0.000253 AC XY: 184AN XY: 727136
GnomAD4 genome AF: 0.000341 AC: 52AN: 152340Hom.: 1 Cov.: 33 AF XY: 0.000295 AC XY: 22AN XY: 74494
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2021 | The c.1471G>T (p.V491L) alteration is located in exon 11 (coding exon 11) of the RABEP2 gene. This alteration results from a G to T substitution at nucleotide position 1471, causing the valine (V) at amino acid position 491 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at